IL108741A0 - Monoclonal antibodies reactive with defined regions of the t cell antigen receptor - Google Patents

Monoclonal antibodies reactive with defined regions of the t cell antigen receptor

Info

Publication number
IL108741A0
IL108741A0 IL10874194A IL10874194A IL108741A0 IL 108741 A0 IL108741 A0 IL 108741A0 IL 10874194 A IL10874194 A IL 10874194A IL 10874194 A IL10874194 A IL 10874194A IL 108741 A0 IL108741 A0 IL 108741A0
Authority
IL
Israel
Prior art keywords
monoclonal antibodies
antigen receptor
cell antigen
antibodies reactive
defined regions
Prior art date
Application number
IL10874194A
Original Assignee
T Cell Sciences Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by T Cell Sciences Inc filed Critical T Cell Sciences Inc
Publication of IL108741A0 publication Critical patent/IL108741A0/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/2803—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against the immunoglobulin superfamily
    • C07K16/2809—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against the immunoglobulin superfamily against the T-cell receptor (TcR)-CD3 complex
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/10—Cells modified by introduction of foreign genetic material
    • C12N5/12—Fused cells, e.g. hybridomas
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/70—Immunoglobulins specific features characterized by effect upon binding to a cell or to an antigen
    • C07K2317/74—Inducing cell proliferation
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S436/00—Chemistry: analytical and immunological testing
    • Y10S436/804—Radioisotope, e.g. radioimmunoassay
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S436/00—Chemistry: analytical and immunological testing
    • Y10S436/811—Test for named disease, body condition or organ function

Landscapes

  • Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biochemistry (AREA)
  • Zoology (AREA)
  • Biotechnology (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • Wood Science & Technology (AREA)
  • Biomedical Technology (AREA)
  • Microbiology (AREA)
  • Cell Biology (AREA)
  • Transplantation (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • General Engineering & Computer Science (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
IL10874194A 1988-12-15 1994-02-22 Monoclonal antibodies reactive with defined regions of the t cell antigen receptor IL108741A0 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US28451188A 1988-12-15 1988-12-15
US34318989A 1989-04-25 1989-04-25
US07/449,692 US5223426A (en) 1988-12-15 1989-12-11 Monoclonal antibodies reactive with defined regions of the t-cell antigen receptor

Publications (1)

Publication Number Publication Date
IL108741A0 true IL108741A0 (en) 1994-05-30

Family

ID=27403469

Family Applications (2)

Application Number Title Priority Date Filing Date
IL9267089A IL92670A (en) 1988-12-15 1989-12-13 Monoclonal antibodies reactive with an epitope of the constant region of the alpha chain of the T cell antigen receptor and the pharmaceutical compositions containing them
IL10874194A IL108741A0 (en) 1988-12-15 1994-02-22 Monoclonal antibodies reactive with defined regions of the t cell antigen receptor

Family Applications Before (1)

Application Number Title Priority Date Filing Date
IL9267089A IL92670A (en) 1988-12-15 1989-12-13 Monoclonal antibodies reactive with an epitope of the constant region of the alpha chain of the T cell antigen receptor and the pharmaceutical compositions containing them

Country Status (7)

Country Link
US (5) US5223426A (en)
EP (2) EP0404912A4 (en)
JP (1) JPH03502762A (en)
KR (1) KR0174540B1 (en)
AU (2) AU643195B2 (en)
IL (2) IL92670A (en)
WO (1) WO1990006758A1 (en)

Families Citing this family (73)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5776093A (en) 1985-07-05 1998-07-07 Immunomedics, Inc. Method for imaging and treating organs and tissues
US5426029A (en) * 1986-03-31 1995-06-20 T Cell Diagnostics, Inc. Therapeutic and diagnostic methods using leukocyte surface antigens
US5766947A (en) * 1988-12-14 1998-06-16 Astra Ab Monoclonal antibodies reactive with an epitope of a Vβ3.1 variable region of a T cell receptor
US5223426A (en) * 1988-12-15 1993-06-29 T Cell Sciences, Inc. Monoclonal antibodies reactive with defined regions of the t-cell antigen receptor
US5837246A (en) * 1989-03-21 1998-11-17 The Immune Response Corporation Vaccination and methods against diseases resulting from pathogenic responses by specific T cell populations
US6221352B1 (en) * 1989-03-21 2001-04-24 The Immune Response Corporation Method of preventing the proliferation of Vβ14 or Vβ17-Expressing T cells
US5612035A (en) * 1989-03-21 1997-03-18 The Immune Response Corporation Vaccination against diseases resulting from pathogenic responses by specific T cell populations
US6207645B1 (en) * 1989-03-21 2001-03-27 The Immune Response Corporation Vaccination and methods against diseases resulting from pathogenic responses by specific T cell populations
US5298396A (en) * 1989-11-15 1994-03-29 National Jewish Center For Immunology And Respiratory Medicine Method for identifying T cells disease involved in autoimmune disease
FR2675155A1 (en) * 1991-04-12 1992-10-16 Roussel Uclaf Nucleotide sequences encoding variable regions of beta chains of the receptors of human T lymphocytes, corresponding peptide segments and the diagnostic and therapeutic applications
US7294712B2 (en) * 1990-06-04 2007-11-13 Aventis Pharma S.A. Nucleotide sequences coding for variable regions of β chains of human T lymphocyte receptors, corresponding peptide segments and the diagnostic and therapeutic uses
JPH06502529A (en) * 1990-08-09 1994-03-24 ナショナル　ジューイッシュ　センター　フォア　イミュノロジィ　アンド　レスパラトリィ　メディスン Method for producing monoclonal antibodies against human T cell receptor elements using recombinant DNA vectors
US6596536B1 (en) * 1991-02-08 2003-07-22 Aventis Pharma S.A. Nucleotide sequences coding for variable regions of the alpha chains of human T lymphocyte receptors, corresponding peptide segments and the diagnostic and therapeutic uses
AU660660B2 (en) * 1991-02-08 1995-07-06 Roussel-Uclaf Nucleotide sequences coding for alpha chain variable regions in human lymphocyte receptors and applications thereof
FR2672616B1 (en) * 1991-02-08 1994-09-23 Roussel Uclaf NUCLEOTIDE SEQUENCES ENCODING VARIABLE REGIONS OF ALPHA CHAINS OF HUMAN T LYMPHOCYTE RECEPTORS, CORRESPONDING PEPTIDE SEGMENTS AND DIAGNOSTIC AND THERAPEUTIC APPLICATIONS.
IE920447A1 (en) * 1991-02-12 1992-08-12 Roussel Uclaf NUCLEOTIDE SEQUENCES CODING FOR ß-CHAIN VARIABLE REGIONS OF¹HUMAN T-LYMPHOCYTE RECEPTORS, CORRESPONDING PEPTIDE SEGMENTS¹AND DIAGNOSTIC AND THERAPEUTIC APPLICATIONS
US6106835A (en) * 1991-04-19 2000-08-22 Tanox, Inc. Modified binding molecules specific for T or B lymphocytes and their use as in vivo immune modulators
CA2065658A1 (en) * 1991-04-19 1992-10-20 Tse-Wen Chang Conjugates of liposomes or microbeads and antibodies specific for t lymphocytes and their use in vivo immune modulators
US5872222A (en) * 1991-04-19 1999-02-16 Tanox Biosystems, Inc. Conjugates of polymers and antibodies specific for T lymphocytes, and their use as adjuvants
US6129916A (en) * 1991-04-19 2000-10-10 Tanox, Inc. Method of Increasing activation on proliferation of T cells using antibody-microbead conjugates
US6197298B1 (en) 1991-04-19 2001-03-06 Tanox, Inc. Modified binding molecules specific for T lymphocytes and their use as in vivo immune modulators in animals
US5747036A (en) * 1991-08-28 1998-05-05 Brigham & Women's Hospital Methods and compositions for detecting and treating a subset of human patients having an autoimmune disease
US5445940A (en) * 1991-08-28 1995-08-29 Brigham & Women's Hospital Methods and compositions for detecting and treating a subset of human patients having an autoimmune disease
US5480895A (en) * 1991-09-27 1996-01-02 New York Society For The Relief Of The Ruptured And Crippled, Maintaining The Hospital For Special Surgery Method of producing antibodies to a restricted population of T lymphocytes, antibodies produced therefrom and methods of use thereof
US5643549A (en) * 1992-02-20 1997-07-01 Rhomed Incorporated Leukostimulatory agent for in vivo leukocyte tagging
US5710262A (en) * 1992-04-17 1998-01-20 Dana-Faber Cancer Institute, Inc. Nucleic acid encoding HB15 polypeptides
GB9325182D0 (en) * 1993-12-08 1994-02-09 T Cell Sciences Inc Humanized antibodies or binding proteins thereof specific for t cell subpopulations exhibiting select beta chain variable regions
US5552300A (en) * 1994-01-13 1996-09-03 T Cell Sciences, Inc. T cell antigen receptor V region proteins and methods of preparation thereof
US5853721A (en) * 1995-01-31 1998-12-29 Hoffmann-La Roche Inc. Antibody to interleukin-12 receptor
IL122233A (en) * 1996-12-06 2001-04-30 Akzo Nobel Nv Method of preparing cell surface monolonal antibodies and pharmaceutical compositions and diagnostic reagents containing them
ZA9710391B (en) * 1996-12-06 1998-06-23 Akzo Nobel Nv Method of preparing a monoclonal antibody, monoclonal antibody, a pharmaceutical composition and a diagnostic reagent.
US6146836A (en) 1997-05-19 2000-11-14 Bayer Corporation Immunoassays using anti-allotypic monoclonal antibodies
US6379909B1 (en) * 1998-06-24 2002-04-30 Alk-Abello A/S Method of detecting an antibody in a liquid sample
WO2000058511A1 (en) 1999-03-26 2000-10-05 Ludwig Institute For Cancer Research Screening and therapy for lymphatic disorders involving the flt4 receptor tyrosine kinase (vegfr-3)
US6764820B2 (en) * 1999-03-26 2004-07-20 Ludwig Institute For Cancer Research Screening for lymphatic disorders involving the FLT4 receptor tyrosine kinase (VEGFR-3)
US6737398B1 (en) * 1999-09-30 2004-05-18 National Jewish Medical And Research Center Modulation of γδ T cells to regulate airway hyperresponsiveness
US7572631B2 (en) * 2000-02-24 2009-08-11 Invitrogen Corporation Activation and expansion of T cells
US7541184B2 (en) * 2000-02-24 2009-06-02 Invitrogen Corporation Activation and expansion of cells
AU5984701A (en) * 2000-05-12 2001-11-20 Univ Oregon Health & Science Method of treating immune pathologies with low dose estrogen
US7462486B2 (en) * 2000-05-12 2008-12-09 Oregon Health & Science University Methods of selecting T cell receptor V peptides for therapeutic use
US20020098516A1 (en) * 2000-10-03 2002-07-25 Boystown National Research Hospital Immunodiagnostic determination of usher syndrome type IIA
US8178098B2 (en) 2001-04-03 2012-05-15 National Jewish Health Method to inhibit airway hyperresponsiveness using aerosolized T cell receptor antibodies
US20030105003A1 (en) 2001-04-05 2003-06-05 Jan Nilsson Peptide-based immunization therapy for treatment of atherosclerosis and development of peptide-based assay for determination of immune responses against oxidized low density lipoprotein
ES2372321T3 (en) * 2001-06-20 2012-01-18 Genentech, Inc. COMPOSITIONS AND METHODS FOR THE DIAGNOSIS AND TREATMENT OF A LUNG TUMOR.
US20090297531A1 (en) * 2001-06-20 2009-12-03 Genentech, Inc. Compositions and methods for the diagnosis and treatment of tumor
US20050169927A1 (en) * 2001-10-02 2005-08-04 Novo Nordisk A/S Human tissue factor antibodies
US20040001830A1 (en) * 2001-10-02 2004-01-01 Per-Ola Freskgaard Human tissue factor antibodies
CA2490401A1 (en) * 2002-06-28 2004-01-08 Xcyte Therapies, Inc. Compositions and methods for restoring immune repertoire in patients with immunological defects related to autoimmunity and organ or hematopoietic stem cell transplantation
US20040175373A1 (en) * 2002-06-28 2004-09-09 Xcyte Therapies, Inc. Compositions and methods for eliminating undesired subpopulations of T cells in patients with immunological defects related to autoimmunity and organ or hematopoietic stem cell transplantation
US20050084967A1 (en) 2002-06-28 2005-04-21 Xcyte Therapies, Inc. Compositions and methods for eliminating undesired subpopulations of T cells in patients with immunological defects related to autoimmunity and organ or hematopoietic stem cell transplantation
US8053197B2 (en) * 2004-07-30 2011-11-08 Oregon Health & Science University Methods for detecting and treating autoimmune disorders
WO2008118792A2 (en) * 2007-03-27 2008-10-02 National Jewish Medical And Research Center Gamma delta t cells and methods of treatment of interleukin-17 related conditions
WO2010098822A1 (en) * 2009-02-24 2010-09-02 Ritter Pharmaceuticals, Inc. Prebiotic formulations and methods of use
US8609605B2 (en) 2009-03-17 2013-12-17 Cardiovax, Llc Immunomodulatory methods for treatment of atherosclerosis via inhibition of CD4+ T cell response to APOB100
US20110091433A1 (en) * 2009-10-19 2011-04-21 Ilham Mohamed Saleh Saeed Abuljadayel Treatment using reprogrammed mature adult cells
WO2011060329A1 (en) 2009-11-14 2011-05-19 Kuang-Yuh Chyu Immunomodulatory methods and systems for treatment and/or prevention of atherosclerosis
EP2637689A2 (en) 2010-11-12 2013-09-18 Cedars-Sinai Medical Center Immunomodulatory methods and systems for treatment and/or prevention of hypertension
JP2013544243A (en) 2010-11-12 2013-12-12 シーダース シナイ メディカル センター Immunomodulation method and system for treatment and / or prevention of aneurysm
WO2015119841A1 (en) * 2014-02-05 2015-08-13 Merck Sharp & Dohme Corp. Role of il-23 and pd-1 in autoreactive immune response
CA2968987C (en) * 2014-12-08 2022-05-10 1Globe Biomedical Co., Ltd. Soluble universal adcc-enhancing synthetic fusion gene and peptide technology and its use thereof
CA2985698C (en) * 2015-05-13 2023-02-28 Ablynx N.V. T cell recruiting polypeptides based on tcr alpha/beta reactivity
JP7020687B2 (en) 2015-09-15 2022-02-16 ボード オブ リージェンツ，ザ ユニバーシティ オブ テキサス システム T-cell receptor (TCR) -binding antibody and its use
US11820823B2 (en) * 2017-10-27 2023-11-21 Kite Pharma, Inc. T cell receptor antigen binding molecules and methods of use thereof
RU2694412C9 (en) 2017-12-25 2019-09-18 Федеральное государственное бюджетное образовательное учреждение высшего образования "Российский национальный исследовательский медицинский университет им. Н.И. Пирогова" Министерства здравоохранения Российской Федерации (ФГБОУ ВО РНИМУ им. Н.И. Пирогова Минздрава России) Monoclonal antibodies and methods of using them
JP7398396B2 (en) 2018-06-01 2023-12-14 ノバルティス アーゲー Binding molecules for BCMA and their uses
RU2712251C1 (en) * 2018-12-25 2020-01-27 Федеральное государственное автономное образовательное учреждение высшего образования "Российский национальный исследовательский медицинский университет имени Н.И. Пирогова" Министерства здравоохранения Российской Федерации (ФГАОУ ВО РНИМУ им. Н.И. Пирогова Минздрава России) Humanised anti-beta 9 chain antibodies of human trbv9 tkp family, and methods of using
RU2711871C1 (en) 2018-12-25 2020-01-23 Федеральное государственное автономное образовательное учреждение высшего образования "Российский национальный исследовательский медицинский университет имени Н.И. Пирогова" Министерства здравоохранения Российской Федерации (ФГАОУ ВО РНИМУ им. Н.И. Пирогова Минздрава России) Monoclonal antibodies which specifically bind to the beta-chain region of the trbv-9 family of the human t-cell receptor, and methods for use thereof
CN114173810A (en) 2019-05-21 2022-03-11 诺华股份有限公司 Trispecific binding molecules directed against BCMA and uses thereof
AU2020279974A1 (en) 2019-05-21 2021-11-18 Novartis Ag CD19 binding molecules and uses thereof
WO2020236797A1 (en) 2019-05-21 2020-11-26 Novartis Ag Variant cd58 domains and uses thereof
CN116249549A (en) 2020-03-27 2023-06-09 诺华股份有限公司 Bispecific combination therapies for the treatment of proliferative diseases and autoimmune disorders
IL302412A (en) 2020-11-06 2023-06-01 Novartis Ag Anti-cd19 agent and b cell targeting agent combination therapy for treating b cell malignancies
EP4240491A1 (en) 2020-11-06 2023-09-13 Novartis AG Cd19 binding molecules and uses thereof

Family Cites Families (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2503331C3 (en) * 1975-01-28 1980-06-12 Dreyer, Karl-August, Dipl.-Ing., 6100 Darmstadt Process for obtaining a signal to switch off battery chargers when they are fully charged
WO1984002848A1 (en) * 1983-01-28 1984-08-02 Centocor Inc Anti-idiotypic antibodies to t cell antigen receptors
US4550086A (en) * 1983-02-16 1985-10-29 Dana-Farber Cancer Institute, Inc. Monoclonal antibodies that recognize human T cells
US4923799A (en) * 1984-02-06 1990-05-08 The Ontario Cancer Institute T cell specific cDNA clone
US4873190A (en) * 1984-06-13 1989-10-10 Massachusetts Institute Of Technology Heterodimeric T lymphocyte receptor
US4634586A (en) * 1984-05-21 1987-01-06 The Board Of Trustees Of The Leland Stanford Junior University Reagent and method for radioimaging leukocytes
EP0180171B1 (en) * 1984-10-31 1992-04-08 Massachusetts Institute Of Technology Process for making a targeted cell susceptible to lysis by cytotoxic t lymphocytes
EP0200350A3 (en) * 1985-04-15 1987-05-13 The Ontario Cancer Institute Nucleic acid encoding a t-cell antigen receptor polypeptide
US4886743A (en) * 1985-04-24 1989-12-12 California Institute Of Technology Diagnostic reagents based on unique sequences within the variable region of the T cell receptor and uses thereof
JPS61254529A (en) * 1985-05-02 1986-11-12 Ishihara Sangyo Kaisha Ltd Production of helper t cell factor having antigenic specificity
US4845026A (en) * 1985-12-03 1989-07-04 T Cell Sciences, Inc. Assay systems for detecting cell-free T cell antigen receptor related molecules and the clinical utilities of the assays
US5340921A (en) * 1986-07-03 1994-08-23 T Cell Sciences, Inc. Γ, δT cell receptor and methods and detection
JPS6330500A (en) * 1986-07-24 1988-02-09 Asahi Chem Ind Co Ltd Antitumor leukocyte inducing material
GB8626413D0 (en) * 1986-11-05 1986-12-03 Gilliland L K Antibodies
US5169938A (en) * 1987-04-25 1992-12-08 Kyowa Hakko Kogyo Co., Ltd. Anti-T cell receptor γ-chain monoclonal antibody
FR2621127B1 (en) * 1987-09-30 1992-01-31 Roussy Inst Gustave MONOCLONAL ANTIBODIES RECOGNIZING A GAMMA CHAIN EPITOPE OF HUMAN T CELL SURFACE RECEPTORS, LINE OF HYBRIDOMA CELLS PRODUCING THE SAME, AND USE OF THIS MONOCLONAL ANTIBODY
PT89107A (en) * 1987-11-30 1989-11-30 Idec Pharma Corp METHOD AND MEANS FOR THE SELECTION OF ANTI-IDIOTIPOSAL ANTIBODIES AND THEIR USE FOR DIAGNOSIS, MONITORING, TREATMENT AND / OR PREVENTION OF CANCER, AUTOMOBILE, OR INFECTIOUS DISEASES
FI891226A (en) * 1988-04-28 1989-10-29 Univ Leland Stanford Junior RESEPTORDETERMINANTER I ANTI-T-CELLER FOER BEHANDLING AV AUTOIMMUNSJUKDOM.
WO1990004180A1 (en) * 1988-10-06 1990-04-19 T Cell Sciences, Inc. Therapeutic and diagnostic methods using soluble t cell surface molecules
US5223426A (en) * 1988-12-15 1993-06-29 T Cell Sciences, Inc. Monoclonal antibodies reactive with defined regions of the t-cell antigen receptor
WO1992012996A2 (en) * 1991-01-22 1992-08-06 The Immune Response Corporation Vaccination and methods against diseases resulting from pathogenic responses by specific t cell populations

Also Published As

Publication number Publication date
AU4838290A (en) 1990-07-10
EP0867189A2 (en) 1998-09-30
IL92670A (en) 1995-03-30
KR900702007A (en) 1990-12-05
US6048526A (en) 2000-04-11
US6171799B1 (en) 2001-01-09
AU4472793A (en) 1993-11-18
EP0867189A3 (en) 1999-03-03
US5976533A (en) 1999-11-02
AU643195B2 (en) 1993-11-11
JPH03502762A (en) 1991-06-27
US5980892A (en) 1999-11-09
AU651931B2 (en) 1994-08-04
EP0404912A1 (en) 1991-01-02
WO1990006758A1 (en) 1990-06-28
EP0404912A4 (en) 1991-01-30
KR0174540B1 (en) 1999-02-01
US5223426A (en) 1993-06-29

Similar Documents

Publication Publication Date Title
IL108741A0 (en) Monoclonal antibodies reactive with defined regions of the t cell antigen receptor
AU1085488A (en) Monoclonal antibodies to a pan-malarial antigen
IL88160A0 (en) Cell lines and monoclonal antibodies
AU566246B2 (en) Monoclonal antibodies reactive with idiotype of anti-dna antibody
GB8608068D0 (en) Monoclonal antibodies
IL90017A0 (en) Monoclonal antibodies
GB8624899D0 (en) Monoclonal antibodies
ZA898777B (en) Monoclonal antibodies
GB2158094B (en) Anti-human igg monoclonal antibody and process for preparing the same
GB8621910D0 (en) Monoclonal antibodies
ZA898499B (en) Anti-fucosylcermiade monoclonal antibody
GB8715347D0 (en) Monoclonal antibodies
JPS6471482A (en) Cell line and antiepiglycanin monoclonal antibody produced thereby
GB8616174D0 (en) Monoclonal antibodies
IL72924A (en) Preparations for use in solid phase immunoassays comprising monoclonal antibodies covalently embedded in their immobilized hybridoma cells
IL108742A0 (en) Monoclonal antibodies reactive with defined regions of the T cell antigen receptor
ZA89258B (en) Monoclonal antibodies
IL86678A0 (en) Hybrid cell line and monoclonal antibodies
GB8820036D0 (en) Monoclonal antibodies
GB8816366D0 (en) Hybridoma cells & monoclonal antibodies
EP0266188A3 (en) Anti-human mesothelial cell monoclonal antibody
GB8610202D0 (en) Monoclonal antibodies
GB8610203D0 (en) Monoclonal antibodies
EP0336441A3 (en) Anti-cpbii monoclonal antibody
AU3979389A (en) Enrichment of antigen-specific polyclonal antibodies through selection of immortal hybrid cells